What is the Hyams Test?
There is no medical test called the "Hyams test" in the colorectal cancer screening literature or in standard medical practice. You may be referring to a guaiac-based fecal occult blood test (gFOBT), which is a well-established screening method for colorectal cancer.
Guaiac-Based Fecal Occult Blood Test (gFOBT)
What It Is
- gFOBT detects blood in stool through the pseudoperoxidase activity of heme or hemoglobin 1
- The test uses guaiac-impregnated slides that change color when blood is present 1
- Common brand names include Hemoccult II and Hemoccult SENSA 1
How It Works
- The test requires collecting 2 samples from each of 3 consecutive bowel movements at home 1
- Samples are applied to guaiac-impregnated cards and developed either in a physician's office or clinical laboratory 1
- The guaiac reagent reacts with the peroxidase-like activity of hemoglobin, producing a blue color change if blood is present 1
Clinical Evidence
- Three large randomized controlled trials demonstrated that annual gFOBT screening reduces colorectal cancer mortality by 15-33% over 8-13 years 1
- Only high-sensitivity gFOBT (sensitivity >70% and specificity >90% for cancer) should be used for screening 1
- The sensitivity of a single gFOBT is low (30-50%), but repeated annual testing can detect up to 92% of cancers 1
Pre-Test Requirements
- Patients must avoid red meat, poultry, fish, and some raw vegetables for 3 days before testing to prevent false positives from dietary pseudoperoxidase activity 1, 2
- NSAIDs and aspirin (>1 adult dose/day) should be avoided for 7 days to reduce false positive results from medication-induced bleeding 2
- Vitamin C exceeding 250 mg should be avoided for 3 days as it can cause false-negative results 2, 3
Critical Pitfalls to Avoid
- Single-sample office FOBT collected after digital rectal examination has unacceptably poor sensitivity (4.9% for advanced neoplasia) and should NEVER be used 2, 3
- Rehydration of gFOBT slides is NOT recommended as it substantially increases false-positive rates and affects test readability 1, 2
- Any positive gFOBT must be followed by colonoscopy, not repeat stool testing 1
Test Performance
- High-sensitivity gFOBT (Hemoccult SENSA) has approximately 64.3% sensitivity for colorectal cancer with 3-sample home testing 2
- Specificity ranges from 86.7-87.5% for high-sensitivity tests 2
- The test must be repeated annually to achieve maximum benefit 1
Comparison with Fecal Immunochemical Tests (FIT)
- FIT has largely replaced gFOBT in many settings due to superior performance characteristics 4
- FIT does not require dietary restrictions and has higher participation rates 5, 4, 6
- FIT demonstrates significantly higher detection rates for advanced adenomas compared to gFOBT 5, 6
- However, gFOBT remains the only stool-based test with randomized controlled trial evidence for mortality reduction 1
Current Recommendations
- Only high-sensitivity gFOBT that have been shown to detect a majority of prevalent colorectal cancer should be used 1
- Annual screening is recommended for average-risk adults aged 50 years and older 1
- Tests should be processed in clinical laboratories rather than physician offices to improve standardization 1, 2
If you were asking about a different test or the term "Hyams" refers to something specific in your context, please clarify and I can provide more targeted information.